Target intelligence / Profile preview

Innate DNA-sensing receptor (IDSRs)

Target
IDSRs
Molecular classification
Receptor, Enzyme, Pattern recognition receptor, Cytosolic DNA sensor
01

Overview

Innate DNA-sensing receptors (IDSRs) are a specialized class of pattern recognition receptors (PRRs) responsible for detecting double-stranded DNA (dsDNA) in cellular compartments where it is normally absent, such as the cytoplasm or endosomes, which typically signals viral or bacterial infection (Paludan & Bowie, 2013). Major members of this group include cyclic GMP-AMP synthase (cGAS), Toll-like receptor 9 (TLR9), and Absent in melanoma 2 (AIM2) (Hornung et al., 2009; Sun et al., 2013). Upon binding DNA, these sensors initiate signaling cascades—most notably the cGAS-STING axis—that result in the production of type I interferons and pro-inflammatory cytokines to orchestrate an immune response (Chen et al., 2016). While essential for host defense, dysregulation or chronic activation of these sensors by self-DNA is a primary driver of autoimmune disorders like systemic lupus erythematosus (SLE) and Aicardi-Goutières syndrome (Crow, 2014). Consequently, these receptors are major therapeutic targets; agonists are being investigated to stimulate anti-tumor immunity in oncology, while inhibitors are being developed to treat chronic inflammatory and autoimmune conditions (Corrales et al., 2015).

Other names
DNA sensorsCytosolic DNA sensorsDNA-sensing pattern recognition receptorsDNA-sensing PRRs
02

Mechanism of action

Modulation of the cGAS-STING pathway to induce or suppress Type I Interferons; Antagonism of endosomal TLR9 to reduce inflammatory signaling; Activation of the AIM2 inflammasome to induce IL-1 beta secretion.

03

Biological functions

Immune responseSignal transductionInflammationApoptosisHost defense
04

Disease associations

InfectionCancerAutoimmune diseaseInflammationNeurodegenerative disease
05

Safety considerations

Systemic cytokine release syndrome (cytokine storm)Induction of autoimmunity or lupus-like syndromesChronic inflammation-mediated tissue damageInjection site reactions for agonists
06

Interacting drugs

Hydroxychloroquine

4 more in the full profile.

07

Biomarkers

Type I Interferon (IFN-alpha/beta) signature (Crow, 2014)Cyclic GMP-AMP (cGAMP) levels (Sun et al., 2013)CXCL10 (IP-10) expression (Corrales et al., 2015)Interleukin-1 beta (IL-1b) secretion (Fernandes-Alnemri et al., 2009)

Beyond the preview

Go deeper on Innate DNA-sensing receptor (IDSRs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Innate DNA-sensing receptor (IDSRs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call